
Opinion: Is the Sputnik V vaccine too good to be true? Without the data, it’s hard to know
Sputnik V, the Covid-19 developed by the Moscow-based Gamaleya Research Institute, was the early rising…

Sputnik V, the Covid-19 developed by the Moscow-based Gamaleya Research Institute, was the early rising…

This week on the “First Opinion Podcast” I’m joined by Danielle Ofri, a physician, writer-editor,…

Over and over, the pandemic has reinforced the reality of racial disparities in the U.S….

The world has reached the era of Covid-19 “vaccine apartheid.” That was the warning this…
.jpg)
On February 25, I got the phone call I had been dreading for years: My…

On February 25, I got the phone call I had been dreading for years: My…

On February 25, I got the phone call I had been dreading for years: My…

DAWSON, Ga. — In every corner of Latasha Taylor’s home are plants she knows nothing…

Amid ongoing calls for greater clinical trial transparency, a new analysis finds just 40% of…
.jpg)
Editor’s note: A livestream of the conversation will be embedded below at 1p.m. ET. Every…

Good morning, everyone, and how are you today? We are doing just fine, thank you,…

Moderna said Tuesday its COVID-19 vaccine strongly protects kids as young as 12, a step…

Some people are vaguely aware of the story of Dr. Lorna Breen. Among physicians and…

After raising $500 million earlier this year — bringing its total funding up to $897…

One morning in 2012, my wife Geri looked in the mirror and failed to recognize…

WEST BOYLSTON, Mass. — When Rachael and Pat Brown rattle off all that their daughter…

In a bid to jumpstart drug development, a bipartisan group of lawmakers introduced a bill…

The Heads of Medicines Agencies, an umbrella group for regulators in 30 European Union countries,…

Somewhere in Paris, in a white room, seated at a white table, a man wearing…

Good morning, everyone, and welcome to another working week. We hope the weekend respite was…

There are few things harder for a physician to say to a patient than “I…

WASHINGTON — Earmarks are back, and so is the health care industry’s insatiable appetite to…

One day last August, as they struggled to figure out whether to lift Covid-19 restrictions,…

This story first appeared in STAT’s sister publication, the Boston Globe. It was reported by…

Freenome, a high-profile startup that aims to develop a blood test to detect colon cancer,…

The leaders of the world’s wealthiest nations and several drug makers took steps to widen…

And so, another working week will soon draw to a close. Not a moment too…
.jpg)
President Biden’s pledge to cut U.S. greenhouse gas emissions in half by 2030 is an…

Both of us lost our dads to Alzheimer’s disease, and both of our families carried…

Allison Savage waited years for surgery to remove the elongated bones at the base of…

How do pandemics end? Who gets to be a TV media expert? And where does…

As it looks to emerge from bankruptcy, Mallinckrodt (MNK) has sold an experimental medicine that…

Researchers have worked for years to create organoids — miniature cellular structures that recapitulate features…

Hello, everyone, and how are you today? The sun is shining brightly this morning on…

The pharmaceutical industry says that if the U.S. reduces the astronomical drug prices paid by…
.jpg)
Some diseases fade away. Others seem to do that, but then come roaring back. That’s…

California lawmakers on Thursday will vote on a bill that would require the state’s growing…

There’s little disputing that an off-the-shelf CAR-T cell therapy for cancer would provide flexibility and…

When doctors prescribe a personalized cell therapy today, the patient they’re trying to help has…

An experimental immunotherapy developed by Bristol Myers Squibb prevented metastatic melanoma from worsening when added…
.jpg)
A drug from the Dutch biotech Merus designed to disrupt a rare genetic alteration is…

A promotional campaign has sparked a legal dispute between Spark Therapeutics and Bluebird Bio (BLUE)…

Amid a furious debate over boosting global distribution of Covid-19 vaccines, more than a dozen…

Hours after the biotech company Iovance announced yet another regulatory delay for its investigational cancer…

Over the past few years, state Medicaid programs have done a better job of disclosing…

Under a contract awarded by the Trump administration, Emergent BioSolutions (EBS) was paid $27 million…

Rise and shine, everyone, another busy day, and especially so here on the Pharmalot campus,…

A growing body of research is identifying the health hazards of hydraulic fracturing, better known…

On Wednesday, five health data analytics companies announced they have banded together to form an…

Chelsea Clinton joins the “First Opinion Podcast” this week to discuss her work in public…